| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2868 | |||||||||||||||||||||||
| Submitter : | Mrs. Sara Annunziata | Date & Time: | 12/11/2006 10:12:10 | |||||||||||||||||||||
| Organization : | Mrs. Sara Annunziata | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I object to ABORTED FETAL CELL LINES being used for the manufacture of vaccines. This must not be allowed to continue.
| ||||||||||||||||||||||||